NB BIOROSE F10

NB BIOROSE F10 is a carefully crafted tablet designed for individuals who face challenges with high cholesterol and triglyceride levels that are not adequately managed by a single medication. It employs a synergistic approach to target various lipid pathways, resulting in a reduction of harmful LDL cholesterol and triglycerides while promoting an increase in beneficial HDL cholesterol. This mechanism provides significant protection against major cardiovascular events, such as heart attacks and strokes. The formulation includes two primary agents: Rosuvastatin, which is a potent HMG-CoA reductase inhibitor that curtails cholesterol production in the liver, effectively lowering both LDL cholesterol and triglycerides. It also possesses additional benefits, including anti-inflammatory properties and stabilization of arterial plaque. The second active component, Fenofibrate, acts as a PPAR-α agonist, targeting high triglyceride levels and boosting HDL cholesterol levels. Together, these agents work to address the co-occurrence of elevated cholesterol and triglyceride levels frequently found in complex dyslipidemia cases. This combination not only aids in normalizing lipid profiles but also strengthens cardiovascular health by reducing risks associated with atherosclerosis and other adverse cardiovascular outcomes. The convenience of once-daily dosing enhances patient compliance and simplifies treatment regimens, making it an optimal choice for managing mixed dyslipidemia and supporting long-term cardiovascular health through effective lipid management.